Company intelligence / Profile preview
Tranquis Therapeutics
San Mateo, California, United Statesorpha.net ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Tranquis Therapeutics has developed a novel immuno-neurology platform targeting myeloid immune cell dysfunction implicated in neurodegenerative disorders. Its lead candidate, TQS‑168—a small molecule PGC‑1α modulator—has received FDA Orphan Drug Designation for ALS and completed Phase 1 trials with plans to initiate Phase 2. Preclinical data show restoration of key metabolic pathways in dysfunctional myeloid cells and promising effects in disease models. The pipeline includes next-generation compounds targeting additional nervous system and immune disorders.
- Therapeutic areas
- Neurology
- Modalities
- small molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of latest available information.
Beyond the preview
Go deeper on Tranquis Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tranquis Therapeutics.